EGFR and neoplasm: Another factor that influences the sensitivity of LB is the tumour burden, particularly the presence of metastases in the liver, bones, and lymph nodes [23]; in these cases, the probability of detecting an EGFR mutation is higher, as reported by Dal Maso et al. (OR: 3.95–8.62).